Assembly Biosciences Inc. Common Stock (ASMB)

About ASMB

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

73

Website

www.assemblybio.com/

Fundamentals

1-day range

$26.36$27.12

Market cap

$420.36M

P/E (trailing)

333.50

P/E (forward)

-12.67

EPS (trailing)

$-1.29

Dividend yield

—

Beta

1.13

Avg. volume

199.5K

Forecasts

4 analyst ratings

Assembly Biosciences Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• ASMB

  Assembly Biosciences Inc. Common Stock

  $33.97

  ▼ 2.39%
  Market cap $420.36MP/E 333.50
  $20.23$39.71
• PBYI

  Puma Biotechnology Inc Common Stock

  $9.07

  ▼ 1.89%
  Market cap $413.30MP/E 18.65
  $4.3$9.51
• LRMR

  Larimar Therapeutics Inc. Common Stock

  $4

  ▼ 1.23%
  Market cap $436.31MP/E —
  $2.72$6.42
• PRTA

  Prothena Corporation plc Ordinary Shares

  $9.35

  ▲ 2.86%
  Market cap $449.19MP/E —
  $7.73$11.8
• BNTC

  Benitec Biopharma Inc. Common Stock

  $12.51

  ▼ 1.30%
  Market cap $451.07MP/E —
  $9.85$16.76
• ENTA

  Enanta Pharmaceuticals Inc. Common Stock

  $13.6

  ▼ 1.45%
  Market cap $387.91MP/E —
  $7.05$17.15
• RCKT

  Rocket Pharmaceuticals Inc. Common Stock

  $3.86

  ▲ 6.49%
  Market cap $386.55MP/E —
  $2.53$5.45

P/E shows — for peers not currently carrying a live signal of their own.

• Jeanette M. Bjorkquist · June 17, 2026 · Sale

  29 @ $23.25
• John G. McHutchison · June 4, 2026 · Grant

  8.0K
• Susan Mahony · June 4, 2026 · Grant

  8.0K
• Johnson-Pratt Lisa · June 4, 2026 · Grant

  8.0K
• Michael Houghton · June 4, 2026 · Grant

  8.0K
• Consylman Gina · June 4, 2026 · Grant

  8.0K
• ALTIG ANTHONY E · June 4, 2026 · Grant

  8.0K
• GILEAD SCIENCES, INC. · May 26, 2026 · Grant

  471.7K @ $26.5
• Jeanette M. Bjorkquist · March 30, 2026 · Sale

  16 @ $27.49
• Jeanette M. Bjorkquist · March 30, 2026 · Sale

  312 @ $26.65
• Nicole S. White · March 30, 2026 · Sale

  9 @ $27.49
• Nicole S. White · March 30, 2026 · Sale

  188 @ $26.65
• Anuj Gaggar · March 29, 2026 · Grant

  14.0K
• Nicole S. White · March 29, 2026 · Grant

  14.0K
• Jeanette M. Bjorkquist · March 29, 2026 · Grant

  3.5K

Institutional Ownership

March 31, 2026

Total shares held

13.42M

Total value held

$371.09M

Institutional holders

71